Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for ARROWHEAD PHARMACEUTICALS INC COMMON STOCK (ARWR).
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2024.
STATE STREET CORP - 31 Dec 2024 SCHEDULE 13G Report for ARROWHEAD PHARMACEUTICALS INC COMMON STOCK (ARWR)
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Symbol
- ARWR
- Shares outstanding
- 125,338,063 shares
- Disclosed Ownership
- 6,016,227 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2025, 06:41:00 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 13 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 4.8% ownership in ARROWHEAD PHARMACEUTICALS INC COMMON STOCK (ARWR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 06:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 4.8% | 6,016,227 | 0 | 5,596,562 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |